Retinal Reports

US Retinal Market Quarterly Updates

Our US Retinal Market Quarterly Updates are designed to keep you up to date with data gathered four times per year on the practice of retinal medicine, both pharmaceutical and surgical. We began this survey process in 2008. These updates are designed to improve your decision-making process with accurate and timely information on a variety of vital practice of medicine issues, doctors’ evaluations of pharmaceuticals and surgical equipment, and the identification of significant trends in the marketplace for  retinal pharmaceuticals and devices.

Additional DescriptionMore Details

Our updates include trend analysis based on comparisons with information gathered in previous years. All information is presented in color charts and tables with concise narratives for enhanced clarity and context.

We measure and analyze the key metrics of the US retina treatments market, including the following topics:

Use of Lucentis, Avastin, and Eylea
IVT Injections
DME Treatments
Corticosteroid Use
Photocoagulation Volume and Photocoagulators Used
Use of Jetrea
Vitrectomy Volume and Location
Disposable Procedure Packs
Reusable and Disposable Instruments

2012 Retina Quarterly Update Image

We also provide a full-year forecast for US retinal procedures (including IVT injections) and a comparison with volumes during the prior year. The survey has been developed in conjunction with retina specialists and industry manufacturers.

Our US Retina Quarterly Market Updates are published each quarter. We have been conducting surveys of ophthalmologists in various subspecialties for 12 years, and our analyses of survey data are used by hundreds of ophthalmological practices and businesses in the ophthalmic industry. Each update can be purchased separately for $3,000, or an annual subscription is available for $10,750.

*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.

VIEW THE TABLE OF CONTENTS FOR THIS REPORT

Product Options

Price: from $4,000.00

Loading Updating cart...

2018 Retinal Surgical Device Report: A Global Market Analysis for 2017 to 2023

Our report on the retinal surgical device market is in its 15th edition, and it is the leading industry source for accurate and relevant information on all aspects of the global retinal surgical device market. The report covers currently commercialized devices, as well as device technologies in development, and it provides forecasts for future market activity. Topics include retinal physiology, the epidemiology of retinal disease, patient economics and reimbursements, and retina specialists who provide care. In addition, we include profiles of the companies that participate in the industry.

 

Additional DescriptionMore Details

The 2018 global retinal surgical device market is approaching $2 billion and is expected to grow to $2.5 billion by 2023. Nearly 80 percent of 2018 revenues will come from a wide range of devices used to perform vitrectomy including, vitrectomy machines, procedure packs, and numerous allied products such as ocular gases, silicone oil, scleral buckles, ocular dyes, light sources, dedicated retina instruments, and cryosurgical devices. Since the number of vitrectomy procedures is the key market driver, we look at the underlying disease states that drive the need for vitrectomies and evaluate the current and forecast number of vitrectomies performed by country or region. With the recent approval of the Bausch + Lomb Vitesse hypersonic vitrector, we focus on the potential advantages of this disruptive technology and how it could broaden the indications for vitrectomy.

*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.

Market Scope’s industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective ophthalmic experience and each data point is driven by a combination of sources, including the following:

• Our proprietary global disease population and demographic models
• Twenty years and counting of ophthalmologist survey data
• Analysis of company published financial reports
• Focused coverage of ophthalmic scientific research, business news and other activities
• Attendance and participation in major, worldwide ophthalmic meetings
• Interviews and long-standing relationships with company executives and practicing ophthalmologists

Our 2018 Retinal Surgical Device Report was released in March 2018. The report is printed in color and is spiral bound for easy reading. The price of the report is $6,000 for a SINGLE USER LICENSE (an electronic PDF copy and/or additional paper copies are available for use within your company for an additional $500 and $300, respectively) or $9,000 for an ENTERPRISE LICENSE (price includes multi-user license, a printable PDF, and supplemental Excel worksheet of tables and figures in the report).

Product Options

Price: from $6,000.00

Loading Updating cart...

2017 Retinal Pharmaceuticals and Biologics Report: A Global Market Analysis for 2016 to 2022

Our report on the retinal pharmaceuticals and biologics market is in its eighth edition. It is a leading industry source for accurate and relevant information on all aspects of the market. We cover prevalence and forecasts for retinal diseases and conditions. We discuss therapeutic approaches and mechanisms of action under investigation. We discuss the market dynamics for currently commercialized products and the rich and crowded pipeline of investigational therapies. We review patient-based economic issues and reimbursement and analyze treatment patterns and trends. We also forecast product demand in units and dollars, and we analyze market shares by product category.

What's New? The 2017 Retinal Pharmaceuticals and Biologics Report has significant enhancements from previous reports, with updated estimates of the prevalence of diabetes and new extended analysis and discussions of diseases.

Additional DescriptionMore Details

We analyze worldwide markets using the following geographic/economic categories: the US, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America and Rest of World. This report includes market data for 2016, and we forecast market performance through 2022.

Market Scope’s 2017 Retinal Pharmaceuticals and Biologics Report provides in-depth coverage of current and future pharmaceuticals and biologics used in treating retinal diseases.

ABOUT THE AUTHOR


Eight Categories Are Analyzed In This Report:

VEGF Inhibitors, PDGF Inhibitors, Neuroprotectors, Complement Cascade Inhibitors, Visual Cycle Modulators, Gene Therapies, Corticosteroids, and Other Mechanisms of Action

Each Market Segment Includes:
An Analysis of Market Competitors and Five‐Year Forecasts for Market Performance

Also Included in This Report:
• Review of Retinal Diseases and Treatments
• Symptoms, Diagnosis, and Treatment of AMD
• Diagnosis and Management of Diabetic Retinopathy and Macular Edema
• An Overview of Other Retinal Diseases and Conditions
• Epidemiology of Retinal Disease
• Patient Economics and Reimbursement
• Retina Specialists and Training
• Current Retinal Pharmaceuticals in the Marketplace
• 27 Company Profiles
• 41 Color Tables and 47 Color Figures

2017 Retina Pharma Graphic

VIEW THE TABLE OF CONTENTS OF THIS REPORT

The 2017 Retinal Pharmaceuticals and Biologics Report: A Global Market Analysis for 2016 to 2022 will be released in October 2017. The report is printed in color and spiral bound for easy reading. Two licensing types are available for this report. The price of the report is $6,800 for a SINGLE USER LICENSE (an electronic PDF copy and/or an additional paper copy is available for use within your company for an additional $500 and $300, respectively). The price of the ENTERPRISE LICENSE is $10,200 (includes a printable PDF and supplemental Excel file with all the tables and figures in the report).

*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.


Market Scope’s industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective ophthalmic experience and each data point is driven by a combination of sources, including the following:


• Our proprietary global disease population and demographic models
• Twenty years and counting of ophthalmologist survey data
• Analysis of company published financial reports
• Focused coverage of ophthalmic scientific research, business news and other activities
• Attendance and participation in major, worldwide ophthalmic meetings
• Interviews and long-standing relationships with company executives and practicing ophthalmologists

Product Options

Price: from $6,800.00

Loading Updating cart...

2017 Ophthalmic Laser Report: A Global Market Analysis for 2016 to 2022 (Photocoagulation, Photodisruption, and SLT

Our report on the ophthalmic laser market is in its seventh edition. It is a leading industry source for accurate and relevant information on all aspects of the market. The report discusses the epidemiology of retinal diseases, glaucoma, and cataracts, plus other diseases and disorders that require laser intervention. The report covers photocoagulation, photodisruption, and SLT lasers. It excludes excimer and femtosecond lasers. We forecast product demand in units and dollars, and we analyze market shares by product category.

Additional DescriptionMore Details

We analyze worldwide markets using the following geographic/economic categories: the US, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America, and Rest of World. This report includes market data for 2016, and we forecast market performance through 2022.

ABOUT THE AUTHOR

Our report is organized into key areas and includes:

• Review of Global Retinal Diseases and Treatment Methods
• Review of Global Glaucoma and Treatment Methods
• Review of Global Cataracts and Treatment Methods
• Global Overview of Ophthalmologists
• Forecast of Photocoagulation Lasers by Region
• Forecast of Photodisruption Lasers by Region
• Forecast of SLT Lasers by Region
• 13 Company Profiles
• 50 Color Tables and 22 Color Figures

2017 Laser Report Graphic

The data included in our reports is based on surveys of ophthalmologists, reviews of clinical data, interviews with company executives, published medical reviews, and analysis of company financial data.

VIEW THE TABLE OF CONTENTS OF THIS REPORT

This edition of our Ophthalmic Laser Report: A Global Market Analysis for 2016 to 2022 was released in June 2017. The report is printed in color and spiral bound for easy reading. Two licensing types are available for this report. The price of the report is $4,000 for a SINGLE USER LICENSE (an electronic PDF copy and/or an additional paper copy is available for use within your company for an additional $500 and $300, respectively). The price of the ENTERPRISE LICENSE is $6,000 (includes a printable PDF and supplemental Excel file with all the tables and figures in the report).

*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.

Market Scope’s industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective ophthalmic experience and each data point is driven by a combination of sources, including the following:

• Our proprietary global disease population and demographic models
• Twenty years and counting of ophthalmologist survey data
• Analysis of company published financial reports
• Focused coverage of ophthalmic scientific research, business news and other activities
• Attendance and participation in major, worldwide ophthalmic meetings
• Interviews and long-standing relationships with company executives and practicing ophthalmologists

Product Options

Price: from $4,000.00

Loading Updating cart...
LoadingUpdating...

Shopping Cart

Your shopping cart is empty
View all of the reports

Note: Report PDFs are not downloadable

PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.